{"title":"Is Any ABCDE Stress Echocardiography Score Equivalent to Stress-Induced Ischaemia? Reply With a Modified 2-Stage Approach.","authors":"Nikolaos Miaris","doi":"10.4070/kcj.2024.0264","DOIUrl":null,"url":null,"abstract":"<p><p>Stress echocardiography has evolved from the sole assessment of regional wall motion abnormalities (RWMAs) to the ABCDE protocol, as recommended by the recent clinical consensus statement from the European Association of Cardiovascular Imaging, reflecting the need for a more systematic patient assessment. Steps A, B, C, D, and E assess RWMAs, lung B-lines, left ventricular contractile reserve, coronary flow velocity reserve (CFVR) in mid-distal left anterior descending artery, and heart rate reserve, respectively. Impairment of CFVR is considered as the earliest abnormality in the ischaemic cascade. While mostly steps A and D have been studied for their relation to obstructive and non-obstructive coronary artery disease, the diagnostic accuracy of steps B, C, and E for chronic coronary syndromes (CCSs) remains unknown, particularly in the context of negative steps A and D. Additionally, while ABCDE steps have been studied for their prognostic significance, there is no evidence of patients management based on this protocol in order to change the estimated risk. These concepts could be depicted in a 2-stage approach. A negative stage 1 (no stress-induced RWMAs as assessed in step A and normal CFVR as assessed in step D) imply good prognosis and non-coronary causes of symptoms should be considered, whereas guidelines for CCSs should be followed in a positive stage 1. Stage 2 includes steps B, C, and E, for further risk stratification or symptoms assessment, but it lacks evidence-based risk-modifying management and is mainly useful when stage 1 is negative and a cardiac origin of symptoms is still suspected.</p>","PeriodicalId":17850,"journal":{"name":"Korean Circulation Journal","volume":"55 1","pages":"1-4"},"PeriodicalIF":3.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11735153/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Korean Circulation Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4070/kcj.2024.0264","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Stress echocardiography has evolved from the sole assessment of regional wall motion abnormalities (RWMAs) to the ABCDE protocol, as recommended by the recent clinical consensus statement from the European Association of Cardiovascular Imaging, reflecting the need for a more systematic patient assessment. Steps A, B, C, D, and E assess RWMAs, lung B-lines, left ventricular contractile reserve, coronary flow velocity reserve (CFVR) in mid-distal left anterior descending artery, and heart rate reserve, respectively. Impairment of CFVR is considered as the earliest abnormality in the ischaemic cascade. While mostly steps A and D have been studied for their relation to obstructive and non-obstructive coronary artery disease, the diagnostic accuracy of steps B, C, and E for chronic coronary syndromes (CCSs) remains unknown, particularly in the context of negative steps A and D. Additionally, while ABCDE steps have been studied for their prognostic significance, there is no evidence of patients management based on this protocol in order to change the estimated risk. These concepts could be depicted in a 2-stage approach. A negative stage 1 (no stress-induced RWMAs as assessed in step A and normal CFVR as assessed in step D) imply good prognosis and non-coronary causes of symptoms should be considered, whereas guidelines for CCSs should be followed in a positive stage 1. Stage 2 includes steps B, C, and E, for further risk stratification or symptoms assessment, but it lacks evidence-based risk-modifying management and is mainly useful when stage 1 is negative and a cardiac origin of symptoms is still suspected.
期刊介绍:
Korean Circulation Journal is the official journal of the Korean Society of Cardiology, the Korean Pediatric Heart Society, the Korean Society of Interventional Cardiology, and the Korean Society of Heart Failure. Abbreviated title is ''Korean Circ J''.
Korean Circulation Journal, established in 1971, is a professional, peer-reviewed journal covering all aspects of cardiovascular medicine, including original articles of basic research and clinical findings, review articles, editorials, images in cardiovascular medicine, and letters to the editor. Korean Circulation Journal is published monthly in English and publishes scientific and state-of-the-art clinical articles aimed at improving human health in general and contributing to the treatment and prevention of cardiovascular diseases in particular.
The journal is published on the official website (https://e-kcj.org). It is indexed in PubMed, PubMed Central, Science Citation Index Expanded (SCIE, Web of Science), Scopus, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, KoreaMed, KoreaMed Synapse and KoMCI, and easily available to wide international researchers